MYOCLONIC EPILEPSY OF LATE-ONSET IN TRISOMY-21 by LI, LM et al.
MYOCLONIC EPILEPSY OF LATE 
ONSET IN TRISOMY 21 
SUMMARY - We report the case of a patient with trisomy 21 (T21) with late onset epilepsy. The electro-
clinical features were of myoclonic jerks on awakening and generalised tonic clonic seizures, with generalised 
spike and wave on EEG, and a progressive dementia. As familial Alzheimer's dementia and progressive myoclonic 
epilepsy (Unverricht-Lundborg type) are both linked to the chromosome 21, this case may represent a distinct 
progressive myoclonic epilepsy related to T21. 
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Epilepsia mioclônica de início tardio na trissomia 21 
RESUMO - Pacientes com trissomia do cromossoma 21 (T21), com o passar dos anos, são propensos a desenvolver 
crises epilépticas parciais concomitantes ao aparecimento de degeneração cerebral do tipo Alzheimer. Pacientes 
com T21 e demência parecem ter risco maior de apresentarem crises epilépticas que outros pacientes com 
degeneração cerebral do tipo Alzheimer. O caso relatado é de um paciente com T21 com epilepsia de início 
tardio. A história clínica consiste de crises mioclônicas ao despertar, ocasionais crises generalizadas tônico-
clônicas, demência e ponta onda generalisada no EEG. Demência do tipo Alzheimer familial é ligada ao 
cromossoma 21, bem como epilepsia mioclônica progressiva (tipo Unverricht-Lundborg). Isto sugere que este 
caso possa representar um tipo distinto de epilepsia mioclônica progressiva, ligado ao cromossoma 21. 
PALAVRAS - CHAVE: epilepsia mioclônica, síndrome de Down, trissomia do cromossoma 21. 
Patients with trisomy 21 (T21) have a higher prevalence of epilepsy than the general 
population1 1 1 2 1 5. Amongst T21 patients, the onset of epilepsy has a bimodal distribution, being more 
common in early childhood and after the third decade1 2 1 5. A dementia of the Alzheimer type is 
frequent in T21, specially after the fourth decade of life 9 1 6. This has become more apparent as the 
life expectancy of T21 has increased over recent years1. Partial seizures are the commonest type of 
seizures described in late onset epilepsy in patients with T21 4 - 1 1 1 2 1 5 . However, Genton and Paglia5-5 
have recently reported three patients with T21 with late onset epilepsy, whose clinical features included 
myoclonic jerks on awakening and tonic clonic seizures. We report here a similar case. 
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CASE REPORT 
A fifty one year old man with a phenotypic diagnosis of T21 was referred from his residential 
institution to our centre for assessment of his seizures. His first seizure occurred at the age of 50, and 
this was described by a witness as a generalised tonic clonic seizure. At least four further generalised 
tonic clonic seizures occurred in the next 12 months. He then developed myoclonic jerks, at a 
frequency of 4 per week, either on waking up, or within half and hour of waking. Treatment with 
carbamazepine 300 mg per day had been started by the referring physician. The E E G (Fig 1) showed 
widespread background anterior predominant slow activity with occasional intermittent generalised 
anterior predominant epileptiform discharges, photic stimulation and hyperventilation were not 
performed because the patient could not cooperate. Treatment with sodium valproate was instituted, 
with the concomitant tappering of carbamazepine, and this lead to an important improvement in the 
frequency of his seizures. The patient, however, died 6 months later. No autopsy was performed. 
COMMENT 
T21 is a common cause of congenital cognitive impairment. Its incidence is approximately 1 
in 700 registered births". The prevalence of epilepsy in T21 is overall around 5 to 6%, increasing up 
to 20% after the third decade15. The prevalence of epilepsy in patients with T21 and dementia4 has 
been found to be eightfold higher than other patients with dementia of Alzheimer type8. 
The onset of epilepsy in T21 may precede clinical dementia". However, the diagnosis of 
dementia in patients with T21 may not be easy, as it may manifest in the early stages only as minor 
behavioural disturbance4. 
The seizure types in patients with late onset epilepsy in T21 have been mostly reported as 
partial seizures 4 1 1 1 2 1 4 1 5 . The E E G findings show in most cases of T21 with epilepsy of late onset 
diffuse background slow, with focal or multifocal epileptiform discharges2-313-14. The clinical features 
of the present case report and the three patients from Genton and Paglia5-6, are characterised by 
epilepsy after the fourth decade, myoclonic jerks on awakening, occasional generalised tonic clonic 
seizures, and generalised epileptiform discharges on E E G , associated with a progressive dementia. 
Disorders of chromosome 21 have been implicated in some types of familial Alzheimer's 
dementia7, and also in progressive myoclonic epilepsy (Unverricht-Lundborg type)10. We speculate 
whether these findings might represent a distinct epileptic syndrome linked to T21. 
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